Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects with Hemophilia B with Inhibitors

NCT05789537 is registered in ClinicalTrials.gov with ApcinteX Ltd as lead sponsor.

NCT NCT05789537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05789537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects with Hemophilia B with Inhibitors
Lead sponsor
ApcinteX Ltd
Phase
Phase 2
Overall status
Terminated
Start date
July 28, 2023
Completion date
February 24, 2025
Enrollment
3 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b, hemophilia b with inhibitor